Demographic, Clinical, and Laboratory Characteristics of Pediatric IgA Vasculitis: A Retrospective Five-Year Single-Center Experience

儿童IgA血管炎的人口统计学、临床和实验室特征:一项回顾性五年单中心研究

阅读:1

Abstract

Background: Immunoglobulin A (IgA) vasculitis is the most common vasculitis of childhood. This study aimed to evaluate the demographic characteristics, clinical manifestations, laboratory findings, prognostic features, differential diagnoses, and treatment approaches of children diagnosed with IgA vasculitis in our clinic. Methods: This retrospective study included children diagnosed with IgA vasculitis between February 2020 and November 2025. Demographic, clinical, laboratory, imaging, biopsy, and treatment data were obtained from medical records. Results: Seventy-four patients were included (mean age: 7.7 ± 3.3 years; 60.8% female), with admissions occurring most frequently in autumn and winter. A preceding infection within the last two weeks was present in 78% of patients. Epstein-Barr virus IgM positivity was detected in three patients and Cytomegalovirus IgM positivity in three patients. Joint, gastrointestinal, and renal involvement were observed in 35, 46, and 30 patients, respectively; testicular involvement was detected in two patients and pneumonic infiltration in one patient. Severe gastrointestinal involvement was observed in six patients (melena in four and intussusception in two). Extensive rheumatologic testing revealed no additional pathology, and skin punch biopsy demonstrated findings consistent with IgA vasculitis in all cases. Corticosteroids were required in 44 patients due to gastrointestinal or renal involvement, or persistent disease. Conclusions: Although IgA vasculitis is generally self-limiting, careful clinical monitoring is essential due to the risk of acute gastrointestinal, testicular, and renal complications, and its potential to mimic other causes of acute abdomen before purpura onset. Extensive rheumatologic testing, broad infectious screening and skin biopsy did not provide additional diagnostic or follow-up value beyond clinical assessment.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。